Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-07-12
2011-07-12
Fay, Zohreh (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S912000
Reexamination Certificate
active
07977385
ABSTRACT:
Methods and preparations for treating disorders of the eye and/or causing dissolution of corneal proteoglycans and organized healing of corneal stroma, softening of the cornea for non-surgical refractive correction of eyesight, removing corneal haze and opacification, inhibiting fibroblasts and preventing corneal fibrosis and scar formation, treating pterigiums and treating corneal neovascularization as well as iris neovascularization. Preparations containing a) urea, b) urea derivatives (e.g., hydroxyurea, thiourea), c) antimetabolites, e) urea, urea derivatives, non-enzymatic proteins, nucleosides, nucleotides and their derivatives (e.g., adenine, adenosine, cytosine, cytadine, guanine, guanitadine, guanidinium, guanidinium chloride, guanidinium salts, thymidine, thymitadine, uradine, uracil, cysteine), reduced thioctic acid, uric acid, calcium acetyl salicylate, ammonium sulfate, isopropyl alcohol, ethanol, polyethylene glycol, polypropylene glycol or other compound capable of causing nonenzymatic dissolution of the corneal protoeglycans or f) any of the possible combinations thereof, are administered to the eye in therapeutically effective amounts.
REFERENCES:
patent: 4409205 (1983-10-01), Shively
patent: 5110493 (1992-05-01), Cherng-Chyi et al.
patent: 5292509 (1994-03-01), Hageman
patent: 5441984 (1995-08-01), Heath, Jr. et al.
patent: 5470881 (1995-11-01), Charlton et al.
patent: 5474985 (1995-12-01), Polansky et al.
patent: 5554187 (1996-09-01), Rizzo, III
patent: 5626865 (1997-05-01), Harris et al.
patent: 5629344 (1997-05-01), Charlton et al.
patent: 5866120 (1999-02-01), Karageozian et al.
patent: 5891084 (1999-04-01), Lee
patent: 5891913 (1999-04-01), Sallmann et al.
patent: 6039943 (2000-03-01), Karageozian et al.
patent: 6132735 (2000-10-01), Harris et al.
patent: 6242468 (2001-06-01), Li et al.
patent: 6335348 (2002-01-01), Ross et al.
patent: 6384056 (2002-05-01), Ross et al.
patent: 6395758 (2002-05-01), Ross et al.
patent: 6399648 (2002-06-01), Ross et al.
patent: 6506788 (2003-01-01), Ross et al.
patent: 6551590 (2003-04-01), Karageozian et al.
patent: 2001/0053347 (2001-12-01), Varani et al.
patent: 0244178 (1987-11-01), None
patent: 0009105 (2000-02-01), None
patent: 0051620 (2000-09-01), None
patent: 03068166 (2003-08-01), None
Hayreh (Exp Review, Opthamol. 2(6), (2007) 889-894.
International Search Report Issued Aug. 20, 2003 in Int'l Application No. PCT/US03/04617.
International Search Report Issued Jul. 13, 2000 in Int'l Application No. PCT/US00/05587.
EP Supplemental Search Report issued Oct. 20, 2004 in EP Application No. 00916034.
International Search Report Issued Aug. 15, 2003 in Int'l Application No. PCT/US03/07700.
EP Supplemental Search Report Issued Mar. 8, 2005 in EP Application No. 03709127.
EP Supplemental Search Report issued Apr. 11, 2005 in EP Application No. EP03711552.
Allen, et al., “Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis”, Exp. Eye Res. Jan. 1996; 62(1):21-8 (Abstract only).
Kawashima, et al., “Effects of mitomycin C on the rat retina”, Documenta Ophthalmologica 92: 229-241, 1996.
Kawamura, et al., “Effects of an anti-prostaglandin agent added to the irrigation solution on damage to the anterior segment in monkey eyes induced by pars plana vitrectomy”, Nippon Ganka Gakkiai Zasshi, Aug. 1989:93(8):823-9 (Abstract only).
Aragon Gabriel Arthuro Carpio
Castillejos David
Floress Jose Luis Gutierres
Karageozian Vicken H.
Park John
Fay Zohreh
Numoda Biotechnologies, Inc.
Panitch Schwarze Belisario & Nadel LLP
LandOfFree
Agents for corneal or intrastromal administration to treat... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agents for corneal or intrastromal administration to treat..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for corneal or intrastromal administration to treat... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2724199